The Oncology Drugs Advisory Committee (ODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA). The committee, consisting of members from academic and clinical oncology biostatistics, the general public, and the pharmaceutical industry, makes non-binding recommendations to both the CDER and CBER

CBer

CBER and similar may refer to:* Center for Biologics Evaluation and Research, one of the six main centers of the Food and Drug Administration* Center for Business and Economic Research, Ball State University research center...

 divisions of the FDA about the advisability of approving new medications to treat cancer

Cancer

Cancer , known medically as a malignant neoplasm, is a large group of different diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumors, and invade nearby parts of the body. The cancer may also spread to more distant parts of the...

.